| Literature DB >> 29534066 |
Xiaolin Xu1, Gita D Mishra1, Annette J Dobson1, Mark Jones1.
Abstract
BACKGROUND: The prevalence of diabetes, heart disease, and stroke multimorbidity (co-occurrence of two or three of these conditions) has increased rapidly. Little is known about how the three conditions progress from one to another sequentially through the life course. We aimed to delineate this progression in middle-aged women and to determine the roles of common risk factors in the accumulation of diabetes, heart disease, and stroke multimorbidity. METHODS ANDEntities:
Mesh:
Year: 2018 PMID: 29534066 PMCID: PMC5849280 DOI: 10.1371/journal.pmed.1002516
Source DB: PubMed Journal: PLoS Med ISSN: 1549-1277 Impact factor: 11.069
Baseline characteristics of women by number of conditions from diabetes, heart disease, and stroke developed during follow-up (N = 11,914).
| Number of conditions | 0 ( | 1 ( | ≥2 ( | |
|---|---|---|---|---|
| 47.5 (1.5) | 47.7 (1.5) | 47.8 (1.4) | <0.001 | |
| 0.327 | ||||
| Australia | 7,215 (76.5) | 1,622 (77.7) | 316 (74.7) | |
| Outside Australia | 2,215 (23.5) | 466 (22.3) | 107 (25.3) | |
| <0.001 | ||||
| Married/de facto | 7,910 (84.2) | 1,742 (83.8) | 318 (75.7) | |
| Separated/divorced/widowed | 1,187 (12.6) | 284 (13.7) | 90 (21.4) | |
| Never married | 302 (3.2) | 54 (2.6) | 12 (2.7) | |
| 0.268 | ||||
| Major cities | 3,462 (36.7) | 725 (34.7) | 141 (33.3) | |
| Inner regions | 3,568 (37.8) | 841 (40.3) | 177 (41.8) | |
| Outer regions | 1,929 (20.5) | 414 (19.8) | 86 (20.3) | |
| Remote/very remote | 469 (5.0) | 108 (5.2) | 19 (4.5) | |
| <0.001 | ||||
| University/higher degree | 1,456 (15.4) | 256 (12.3) | 40 (9.5) | |
| Trade/apprenticeship/diploma | 1,919 (20.4) | 365 (17.5) | 82 (19.4) | |
| High school certificate | 1,623 (17.2) | 351 (16.8) | 63 (14.9) | |
| No/low qualifications | 4,432 (47.0) | 1,116 (53.5) | 238 (56.3) | |
| <0.001 | ||||
| Easy/not bad | 5,601 (59.6) | 1,097 (52.8) | 176 (42.0) | |
| Sometimes difficult | 2,610 (27.8) | 633 (30.5) | 131 (31.3) | |
| Impossible/difficult always | 1,185 (12.6) | 348 (16.8) | 112 (26.7) | |
| Underweight (<18.5 kg/m2) | 165 (1.8) | 26 (1.3) | 4 (1.0) | <0.001 |
| Normal weight (18.5–24.9 kg/m2) | 5,130 (55.6) | 722 (35.8) | 129 (31.2) | |
| Overweight (25–29.9 kg/m2) | 2,611 (28.3) | 637 (31.6) | 126 (30.5) | |
| Obese (≥30 kg/m2) | 1,318 (14.3) | 630 (31.3) | 154 (37.3) | |
| 734 (8.1) | 287 (14.4) | 72 (18.1) | <0.001 | |
| <0.001 | ||||
| High ( | 1,640 (17.5) | 253 (12.2) | 59 (14.0) | |
| Moderate (600–1,199 MET min/week) | 2,485 (26.5) | 490 (23.7) | 103 (24.4) | |
| Low (40–599 MET min/week) | 2,881 (30.7) | 668 (32.2) | 121 (28.6) | |
| Nil/sedentary (0–39 MET min/week) | 2,375 (25.3) | 661 (31.9) | 140 (33.1) | |
| <0.001 | ||||
| Never-smoker | 5,077 (55.0) | 1,048 (51.6) | 178 (43.7) | |
| Ex-smoker | 2,629 (28.5) | 601 (29.6) | 117 (28.8) | |
| Current smoker | 1,521 (16.5) | 383 (18.9) | 112 (27.5) | |
| Depression/anxiety | 997 (11.0) | 229 (11.5) | 63 (15.8) | 0.010 |
| COPD | 653 (7.2) | 136 (6.8) | 38 (9.6) | 0.154 |
| Asthma | 730 (8.0) | 187 (9.4) | 40 (10.1) | 0.067 |
| Cancer | 405 (4.5) | 101 (5.1) | 28 (7.0) | 0.036 |
| Arthritis | 1,662 (20.4) | 528 (28.3) | 153 (40.9) | <0.001 |
| Osteoporosis | 122 (1.3) | 30 (1.5) | 9 (2.3) | 0.286 |
Due to missing data, the sum for each characteristic may not equal n.
aP values from ANOVA or chi-squared tests.
Abbreviations: ANOVA, analysis of variance; BMI, body mass index; COPD, chronic obstructive pulmonary disease; MET, metabolic equivalent.
Associations of time-varying sociodemographic and lifestyle factors with 3-year incidence of one condition and accumulation of multimorbidity (N = 11,941).
| Characteristics | Number of new condition(s) | |
|---|---|---|
| 1 | ≥2 | |
| 1.07 (1.04–1.11) | 1.03 (0.96–1.11) | |
| Married/de facto | Ref | Ref |
| Separated/divorced/widowed | 1.03 (0.92–1.17) | 1.55 (1.21–1.98) |
| Never married | 1.00 (0.75–1.32) | 1.62 (0.93–2.83) |
| Major cities | Ref | Ref |
| Inner regions | 1.03 (0.93–1.15) | 1.23 (0.96–1.58) |
| Outer regions | 0.99 (0.86–1.13) | 1.12 (0.82–1.52) |
| Remote/very remote | 1.04 (0.81–1.32) | 0.97 (0.52–1.82) |
| University/higher degree | Ref | Ref |
| Trade/apprenticeship/diploma | 1.03 (0.87–1.22) | 1.29 (0.86–1.93) |
| High school certificate | 1.18 (0.99–1.40) | 1.27 (0.83–1.94) |
| No qualifications | 1.18 (1.02–1.37) | 1.45 (1.01–2.10) |
| Australia | Ref | Ref |
| Outside Australia | 1.11 (0.99–1.24) | 1.61 (1.26–2.05) |
| Easy/not bad | Ref | Ref |
| Sometimes difficult | 1.18 (1.05–1.32) | 0.97 (0.73–1.28) |
| Impossible/difficult always | 1.46 (1.28–1.66) | 1.72 (1.31–2.26) |
| Underweight (<18.5 kg/m2) | 1.39 (0.88–2.19) | 1.75 (0.63–4.85) |
| Normal weight (18.5–24.9 kg/m2) | Ref | Ref |
| Overweight (25–29.9 kg/m2) | 1.50 (1.32–1.70) | 1.77 (1.30–2.43) |
| Obese (≥30 kg/m2) | 2.58 (2.28–2.92) | 3.01 (2.21–4.08) |
| No | Ref | Ref |
| Yes | 1.55 (1.40–1.71) | 2.19 (1.74–2.75) |
| High (≥1,200 MET min/week) | Ref | Ref |
| Moderate (600–1,199 MET min/week) | 1.08 (0.94–1.23) | 0.93 (0.67–1.28) |
| Low (40–599 MET min/week) | 1.13 (1.00–1.28) | 1.06 (0.79–1.41) |
| Nil/sedentary (0–39 MET min/week) | 1.22 (1.07–1.41) | 1.38 (1.02–1.86) |
| Never-smoker | Ref | Ref |
| Ex-smoker | 1.07 (0.96–1.18) | 1.22 (0.96–1.55) |
| Current smoker | 1.28 (1.11–1.48) | 1.78 (1.31–2.42) |
| Depression/anxiety | 1.25 (1.13–1.39) | 1.46 (1.17–1.83) |
| COPD | 1.06 (0.94–1.21) | 1.17 (0.90–1.52) |
| Asthma | 1.14 (1.01–1.29) | 1.34 (1.04–1.72) |
| Cancer | 1.06 (0.91–1.24) | 1.49 (1.11–1.99) |
| Arthritis | 1.20 (1.07–1.35) | 1.45 (1.13–1.86) |
| Osteoporosis | 1.10 (0.94–1.29) | 1.45 (1.07–1.96) |
aindicates the transition from none or one to two or three, or from two to three conditions.
bnot time-varying.
The results (ORs and 95% CI) were estimated using cumulative incidence of multimorbidity (1 or ≥2) at each survey regressed on covariate values at the previous survey, compared with women who developed 0 new conditions. The model was adjusted for all predictors shown in the table.
Abbreviations: BMI, body mass index; CI, confidence interval; COPD, chronic obstructive pulmonary disease; MET, metabolic equivalent; OR, odds ratio.